Central adiposity and insulin resistance play an initiating role in the cardiometabolic syndrome, significantly impacting preclinical cardiovascular structure and function such as diastolic blood pressure and myocardial oxygen demand.
Answers are grounded in this paper and cite their sources.
Central adiposity and insulin resistance may influence diastolic BP and myocardial oxygen demand; hypothesis-generating from cross-sectional data and needs prospective validation.
The cardiometabolic syndrome (CMS) has been an organizing conceptual framework for subclinical cardiovascular pathophysiology. Using cross-sectional data from 338 healthy men and women aged 18 to 55 years, the study examined the role of central adiposity and insulin sensitivity and assessed potential relationships with other metabolic indices (insulin sensitivity, glucose tolerance, fibrinolysis, lipidemia, endothelial function, and inflammation) and measures of cardiac structure and function (cardiac mass, compliance and contractility, myocardial oxygen demand, and blood pressure). Structural equation modeling analyses, which controlled for sex, age, and race, demonstrated good fit to the data. The derived relationships provided a physiologically consistent model of CMS, with an initiating role for central adiposity and insulin resistance. The model accounted for 30% and 82% of the variance in diastolic blood pressure and myocardial oxygen demand, respectively. The findings suggest predominant pathways through which subclinical metabolic processes may exert pathogenic impact on the heart and vasculature.
No takes yet. Share an insight, caveat, or question.
Klaus et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: